Page last updated: 2024-08-25

fluindione and Body Weight

fluindione has been researched along with Body Weight in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andro, M; Berndt, C; Duverlie, C; Emmerich, J; Golmard, JL; Gouin-Thibault, I; Lacut, K; Le Gal, G; Loriot, MA; Mahé, I; Moreau, C; Pautas, E; Peyron, I; Siguret, V	1
Sakaan, S; Sands, CW; Self, TH; Wallace, JL	1
Becquemont, L; Delavenne, X; Diquet, B; Jaillon, P; Lebot, M; Robert, A; Rousseau, A; Tod, M; Verstuyft, C	1

Reviews

1 review(s) available for fluindione and Body Weight

Article	Year
Effect of Body Weight on Dose of Vitamin K Antagonists. Southern medical journal, 2015, Volume: 108, Issue:10 Topics: Acenocoumarol; Anticoagulants; Body Weight; Comorbidity; Drug Dosage Calculations; Humans; Obesity; Obesity, Morbid; Phenindione; Phenprocoumon; Vitamin K; Warfarin	2015

Trials

1 trial(s) available for fluindione and Body Weight

Article	Year
A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy. Clinical pharmacokinetics, 2012, Jan-01, Volume: 51, Issue:1 Topics: Acenocoumarol; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Body Weight; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; International Normalized Ratio; Male; Mixed Function Oxygenases; Models, Biological; Phenindione; Polymorphism, Genetic; Smoking; Vitamin K Epoxide Reductases	2012

Article

Year

A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy.

Clinical pharmacokinetics, 2012, Jan-01, Volume: 51, Issue:1

Topics: Acenocoumarol; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Body Weight; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; International Normalized Ratio; Male; Mixed Function Oxygenases; Models, Biological; Phenindione; Polymorphism, Genetic; Smoking; Vitamin K Epoxide Reductases

2012

Other Studies

1 other study(ies) available for fluindione and Body Weight

Article	Year
A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone. Thrombosis and haemostasis, 2014, Apr-01, Volume: 111, Issue:4 Topics: Aged; Aged, 80 and over; Amiodarone; Body Weight; Drug Dosage Calculations; Female; Gene-Environment Interaction; Genotype; Heart Rate; Humans; Inactivation, Metabolic; Male; Models, Biological; Pharmacogenetics; Phenindione; Polymorphism, Genetic; Vascular Resistance; Vitamin K	2014

Article

Year

A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone.

Thrombosis and haemostasis, 2014, Apr-01, Volume: 111, Issue:4

Topics: Aged; Aged, 80 and over; Amiodarone; Body Weight; Drug Dosage Calculations; Female; Gene-Environment Interaction; Genotype; Heart Rate; Humans; Inactivation, Metabolic; Male; Models, Biological; Pharmacogenetics; Phenindione; Polymorphism, Genetic; Vascular Resistance; Vitamin K

2014